India's FSSAI Issues Notices to Nestlé India and Hindustan Unilever
On October 19, the Food Safety and Standards Authority of India (FSSAI) issued show-cause notices to Nestlé India and Hindustan Unilever. These notices address specialized-nutrition claims and labeling obligations related to two nutrition products: Hindustan Unilever’s Horlicks Mother’s Plus Kesar and Nestlé’s Resource Renal powder.
Details of the Notices
The notice for Horlicks Mother’s Plus Kesar focuses on the claims about maternal nutrition and fetal health, specifically the assertion that the beverage supports a healthy fetal birth weight. The FSSAI raised concerns that these claims might be misleading as they imply direct physiological benefits without established clinical evidence, potentially violating the Food Safety and Standards Advertising and Claims Regulations, 2018. Other product descriptions queried include those promoting benefits from proteins, fatty acids, and the claim of no added sugar, as seen in advertising and e-commerce listings.
Nestlé’s Resource Renal powder, designed for dietary management in chronic kidney disease, was found lacking necessary pre-market approvals stipulated by the 2022 Foods for Special Medical Purposes rules. Additionally, the packaging lacked the required vegetarian identification marks as per the Food Safety and Standards Labelling and Display Regulations, 2020.
Consequences and Responses
FSSAI has requested that both companies provide technical explanations within a specified period, with evidence backing their claims' scientific validity. Failure to provide satisfactory responses may result in actions under India's food safety regulations, such as marketing restrictions, product recalls, and withdrawal of commercial licenses.
The notices reflect a broader scrutiny of health-food beverages, maternal supplements, and medical-nutrition products sold in Indian markets, including supermarkets and online platforms. Authorities are examining the claims made in product packaging, online listings, and promotional material.
Broader Context
The products in question use specialized dairy ingredients like demineralized whey solids and ultrafiltered milk-protein isolates. These ingredients are frequently found in clinical renal diets, maternal beverages, and fortified dairy products. Thus, the proceedings against Hindustan Unilever and Nestlé India address both product claims and compliance with regulatory standards.
